This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Synta Pharmaceuticals

Another under-$10 stock in the biotechnology and drugs complex that's setting up to trigger a big breakout trade is Synta Pharmaceuticals (SNTA), which is focused on discovering, developing and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. This stock has been on a tear so far in 2012, with shares up a whopping 75%.

If you take a look at the chart for Synta Pharmaceuticals, you'll see a stock that has been on fire and uptrending strong for the last three months, with shares soaring from $4.40 to its recent high of $8.45 a share. During that monster uptrend, shares of SNTA have consistently made higher lows and higher highs, which his bullish technical price action. Just recently, SNTA saw heavy upside volume flows as the stock bounced right off its 50-day moving average. That action has now pushed SNTA within range of triggering a major breakout trade.

Market players should now look for long-biased trades in SNTA once it triggers a break out above some near-term overhead resistance levels at $8.45 to $8.50 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 873,200 shares. If that breakout triggers soon, then SNTA will enter new 52-week-high territory and likely trend north of $10 a share.

Traders can look to buy SNTA off any weakness and simply use a stop that sits just below some near-term support at $7.90 to $7.50 a share. One could also buy off strength once SNTA clears those breakout levels with volume, and then simple use a stop that sits just below $7.90 a share.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AEZS $4.05 0.00%
AMPE $4.21 0.00%
CIM $14.20 0.00%
GURE $1.51 0.00%
SNTA $0.40 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs